ArticleFrontiers in cardiovascular medicine2026
Intramyocardial dissecting hematoma after anterior myocardial infarction in a 36-year-old patient: a rare case report.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intramyocardial dissecting hematoma (IDH) is a rare and potentially fatal form of myocardial rupture that usually occurs following acute myocardial infarction (AMI). Due to its low incidence and nonspecific clinical manifestations, IDH is frequently misdiagnosed as left ventricular thrombus or pseudoaneurysm. Multimodality imaging, particularly cardiac magnetic resonance (CMR), plays a pivotal role in establishing the diagnosis and guiding treatment strategies. Case presentation: A 36-year-old man with a long-term smoking history presented with progressive chest tightness and dyspnea for two weeks. Electrocardiography demonstrated pathological Q waves with persistent ST-segment elevation in leads V2-V6, suggestive of subacute anterior myocardial infarction. Laboratory investigations revealed elevated cardiac troponin T and markedly increased N-terminal pro-brain natriuretic peptide levels. Transthoracic echocardiography showed severe left ventricular systolic dysfunction with a left ventricular ejection fraction (LVEF) of 29% and a heterogeneous apical mass measuring 63 × 57 × 25 mm. Contrast-enhanced computed tomography and cardiac magnetic resonance imaging identified a large lesion extending from the interventricular septum to the apex, highly suggestive of intramyocardial dissecting hematoma. Coronary angiography revealed severe proximal stenosis and complete mid-segment occlusion of the left anterior descending artery (LAD). The patient underwent successful percutaneous coronary intervention with implantation of three drug-eluting stents, achieving TIMI grade 3 flow. Following guideline-directed medical therapy, the patient's symptoms improved significantly without hemodynamic deterioration or hematoma progression. Conclusion: This case highlights the importance of considering IDH in patients with subacute myocardial infarction presenting with left ventricular masses. Multimodality imaging, particularly CMR, is essential for differential diagnosis and therapeutic decision-making. Conservative management after successful revascularization may be feasible in hemodynamically stable patients with IDH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.